Abstract:Dietary fibre regulates blood pressure (BP) through gut microbial production of acidic metabolites called short-chain fatty acids (SCFAs). The acidic environment in the large intestine activates a proton-sensing G-protein coupled receptor, GPR65. We aimed to characterize the luminal pH in the intestine of hypertensive patients and normotensive individuals, and to validate in a murine model that dietary fibre intake is a critical determinant for intestinal pH. Furthermore, we aimed to determine whether pH-sensing by GPR65 mediates the cardiovascular protection conferred by dietary fibre. 15 normotensive and 40 hypertensive (16 treated) participants had ambulatory BP profiles recorded using a Mobil-O-Graph device (CardioScan). Their intestinal luminal pH was measured in real-time by a SmartPillTM Motility Testing System (Medtronic). Analyses were performed on SPSS. Intestinal pH of C57BL/6J wild-type (WT) mice was measured after a 7-day dietary intervention of high-fibre (HF) or low-fibre (LF) diets (n = 5/group). Male WT and Gpr65-/- mice fed with HF or LF diets were implanted with minipumps containing angiotensin II (Ang-II, 0.5 mg/kg/day, 28 days, n = 11–12/group). BP was measured by tail-cuff, cardiac function by ultrasound, and fibrosis by Massons trichrome staining. Compared to normotensive individuals, hypertensive participants had higher colonic minimum pH (mean ± SEM: 5.03 ± 0.08 vs 5.22 ± 0.34, the beta coefficient = 2.98, P = 0.024 adjusted for age, sex, BMI), driven by changes in the transverse colon where dietary fibre is fermented. In our murine model, HF fed mice exhibited lower colonic pH compared to LF fed mice (HF vs LF, 6.03 ± 0.42 vs 7.58 ± 0.31, P < 0.001). This was abolished when mice were treated with antibiotics. Under HF diet, Ang-II treated Gpr65-/- mice had significantly higher BP (mean arterial pressure, WT vs Gpr65-/-, 90.7 ± 2.22 vs 101.3 ± 1.82mmHg, P = 0.022), heart to tibia length ratio (0.0096 ± 0.0004 vs 0.0112 ± 0.0018 g/mm, P = 0.036), left ventricle posterior wall in the diastole (0.831 ± 0.016 vs 0.966 ± 0.020 mm, P = 0.010), cardiac fibrosis (1.44 ± 0.15% vs 2.30 ± 0.09%, P = 0.026) and lower ejection fraction (65.65 ± 1.94% vs 54.65 ± 1.60%, P < 0.001) and fractional shortening (22.70 ± 1.52% vs 15.63 ± 0.69%, P < 0.001) than Ang-II treated WT mice. The cardiovascular impact of Gpr65 genotype when Ang-II mice were fed with LF diet was negligible (All P > 0.05). This is the first evidence hypertensive participants have a higher luminal pH in the colon. This likely results from the difference in dietary fibre intake, which in a murine model profoundly determined the colonic pH. Low pH activates GPR65 signalling, which underlies the cardiovascular protection by dietary fibre. Our findings demonstrate a novel mechanism for BP regulation.

High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice

Gut microbiota might mediate the benefits of high-fiber/acetate diet to cardiac hypertrophy mice

Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure

AW-NI-2: A HIGH-FIBRE DIET ATTENUATES HYPERTENSION BY IMPROVING GUT BARRIER INTEGRITY VIA SCFA-RECEPTOR SIGNALLING

Fiber Derived Microbial Metabolites Prevent Acute Kidney Injury Through G-Protein Coupled Receptors and HDAC Inhibition

Fenugreek galactomannan and citrus pectin improve several parameters associated with glucose metabolism and modulate gut microbiota in mice

A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model

Dietary fiber intake impacts gut bacterial and viral populations in a hypertensive mouse model

Dietary Fruit and Vegetable Supplementation Suppresses Diet-Induced Atherosclerosis in LDL Receptor Knockout Mice

High fiber diet attenuate the inflammation and adverse remodeling of myocardial infarction via modulation of gut microbiota and metabolites

Dietary Nitrate and Corresponding Gut Microbiota Prevent Cardiac Dysfunction in Obese Mice

PS-B11-9: LOW COLONIC PH AND PROTON-SENSOR GPR65: A MISSING BRIDGE LINKING DIET, GUT MICROBIOTA AND CARDIOVASCULAR HEALTH

Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E−/− mice

Potassium Alginate Oligosaccharides Alter Gut Microbiota, and Have Potential to Prevent the Development of Hypertension and Heart Failure in Spontaneously Hypertensive Rats

Fiber Diet-Mediated Increases in Short Chain Fatty Acids Alleviate Western Diet Induced Metabolic Dysfunction

Abstract MP28: A New Gut Microbial Metabolite Derived From Low Fibre Intake

Beyond gut feelings: how the gut microbiota regulates blood pressure

Acacetin Exert Antioxidant Potential Against Atherosclerosis Through Nrf2 Pathway in Apoe-/- Mice

Glycan Biosynthesis Ability of Gut Microbiota Increased in Primary Hypertension Patients Taking Antihypertension Medications and Potentially Promoted by Macrophage-Adenosine Monophosphate-Activated Protein Kinase

Effects of Dietary Fiber Supplementation on Fatty Acid Metabolism and Intestinal Microbiota Diversity in C57BL/6J Mice Fed with a High-Fat Diet

Gut Microbiota Regulate Saturated Free Fatty Acid Metabolism in Heart Failure